🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchMonthly semaglutide depot formulation — my results so far Page 6

Monthly semaglutide depot formulation — my results so far

tony_orlando Mon, Jul 22, 2024 at 3:23 PM 39 replies 2,686 viewsPage 6 of 8
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Aug 13, 2024 at 9:14 PM#26
Dr.EndoEP said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Adding the part of the answer the thread has not reached. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Ask again with the specifics and you will get a better answer than this one.

3 1LeilaHI, marcus_mpls, DeniseRN_TPA
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Aug 16, 2024 at 4:05 PM#27

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Last edited: Aug 16, 2024 at 7:05 PM
4 2hank_denver, carlos_SATX, sophie_paris and 1 other
Reply Quote Save Share Report
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Aug 19, 2024 at 10:55 AM#28

One thing that is still open after Dr.EndoEP’s answer:

How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?

5 3traveltech_sara, AttorneyGrant, DebRD_ATL and 2 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Aug 22, 2024 at 5:43 AM#29
SleepDoc_PDX said:
One habit that pays for itself: post the method alongside the number.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

6 4fiona_VT, denise_HTX, raj_cambridge and 3 others
Reply Quote Save Share Report
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
Aug 25, 2024 at 12:30 AM#30

Reporting back.

Update. I did go to 2.4mg in the end, and the honest report is that it bought me less than the step before it and cost me two bad weeks. Worth knowing rather than worth repeating.

Last edited: Aug 25, 2024 at 1:30 AM
28 1KetoKyle, CanadaChris, ZaraB_AL and 25 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register